Sustainable Community-Wide Model to Enhance Cancer Data Usage and Utility.
The paper describes an NCI childhood-cancer Data Jamboree in which more than 120 participants formed 23 multidisciplinary teams to reuse shared data, develop projects, and provide feedback on improving data utility.
Open original publication →What the AI sees
The paper describes an NCI childhood-cancer Data Jamboree in which more than 120 participants formed 23 multidisciplinary teams to reuse shared data, develop projects, and provide feedback on improving data utility.
Research significance
The reported evidence supports the feasibility of a community-wide, FAIR-oriented collaborative event; it is an inference—not demonstrated here—that broader data reuse and interdisciplinary analysis could generate diagnostic or therapeutic hypotheses and ultimately improve pediatric cancer outcomes.
Source abstract
Despite vast investments in data collection, generation, and sharing from childhood cancer studies, for example, Gabriella Miller Kids First Research Program, Childhood Cancer Data Initiative, and other efforts, secondary use of data remains a challenge especially for rare diseases. The National Cancer Institute (NCI) Office of Data Sharing (ODS) aimed to promote FAIR (Findable, Accessible, Interoperable, Reusable) data sharing practices to enhance data utility, accelerate discovery, and foster interdisciplinary collaboration. NCI ODS launched its inaugural Data Jamboree focusing on childhood cancer alongside its third Annual Symposium in September 2025. Over 120 participants with diverse backgrounds coalesced into 23 multidisciplinary teams to solve real-world problems in a collaborative setting. The Jamboree built a diverse pool of data users and catalyzed pediatric cancer research, with several project findings being prepared for publication. Moreover, key feedback and recommendations for areas of improvement were provided to NCI in real time. The event highlighted the power of team science, data sharing, use, and reuse to accelerate childhood cancer research and improve diagnostic and therapeutic outcomes.